Department of Clinical Medicine

Biomarkers and Neuroimmunology

Discover the frontier of groundbreaking research at the intersection of neuroimmunology and disease biomarkers. Our research group, dedicated to unraveling the mysteries of the nervous system's intricate relationship with the immune system, is poised at the forefront of scientific exploration. With a commitment to advancing our understanding of neurodegenerative disorders, we strive to unlock crucial insights that will pave the way for innovative diagnostics and treatments.

NDB Group
From the left, back row: Eirik Solheim, Marie Ytterdal, Jonas Bull Haugsøen, Kjell Inge Erikstad, Torbjørn Kråkenes. From the left, middle row: Hanne Linda Nakkestad, Kibret Mazengia, Liesbeth Kroondijk, Shamundeeswari Anandan, Cecilie Totland, Christian Vedeler (Group Leader). From the left, front row: Elisabeth Claire Evjenth, Anna Engan Aamodt, Yola Gerking, Mette Haugen. "Not included in the picture: Ida Herdlevær, Håkon Olsen & Dimitrios Kleftogiannis."
Group Members

Main content

About Us:

Welcome to the Neuroimmunology and Disease Biomarkers Research Group! Our mission is to unravel the complexities of neuroimmunology and identify biomarkers that will transform the diagnosis, prognosis, and treatment of debilitating diseases.

Led by Professor Christian Vedeler, our group is dedicated to exploring the intersection of the nervous and immune systems to advance our understanding of neurodegenerative disorders. We focus on two key areas: Paraneoplastic Neurological Syndromes (PNS) and Multiple Sclerosis (MS).

Paraneoplastic Neurological Syndromes (PNS) Research Group: While there are various forms of PNS, we are focusing on the most common type called Paraneoplastic Cerebellar Degeneration (PCD). It is an immune-mediated disorder that intersects with breast or gynecological cancers and leads to a degeneration of the cerebellum resulting in a severe impairment of the motor coordination. Our researchers aim to contribute to the understanding of PCD  how the immune system, designed to combat cancer, mistakenly targets components of the nervous system in this disease.

Multiple Sclerosis (MS) Research Group: In our MS research, we are interested in investigating the different forms of this complex autoimmune disease. We aim to unravel the causes of MS, where autoimmune reactions target the protective myelin sheath surrounding nerve fibers in the central nervous system, resulting in a range of neurological symptoms. With a focus on biomarker research, we aim to identify markers that enhance diagnostic precision, predict disease progression, and guide treatment decisions.

We invite you to explore our website, learn about our research, and stay updated on our latest findings and events. Whether you're a researcher, potential collaborator, or simply curious about neuroimmunology and disease biomarkers, we welcome you to join us on this journey of discovery.

  1. Paraneoplastic Neurological Syndromes (PNS) research group
  2. Multiple sclerosis research group